Wells Fargo’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.4K | Buy |
20,284
+1,438
| +8% | +$4.85K | ﹤0.01% | 4985 |
|
|
2025
Q1 | $72.7K | Buy |
18,846
+418
| +2% | +$1.61K | ﹤0.01% | 4806 |
|
|
2024
Q4 | $114K | Buy |
18,428
+4,013
| +28% | +$24.8K | ﹤0.01% | 4643 |
|
|
2024
Q3 | $77.6K | Buy |
14,415
+618
| +4% | +$3.33K | ﹤0.01% | 4762 |
|
|
2024
Q2 | $46.2K | Buy |
13,797
+2,291
| +20% | +$7.68K | ﹤0.01% | 4959 |
|
|
2024
Q1 | $46.4K | Buy |
11,506
+1,484
| +15% | +$5.98K | ﹤0.01% | 4905 |
|
|
2023
Q4 | $26.6K | Buy |
10,022
+1,990
| +25% | +$5.27K | ﹤0.01% | 5101 |
|
|
2023
Q3 | $19K | Sell |
8,032
-4,431
| -36% | -$10.5K | ﹤0.01% | 5257 |
|
|
2023
Q2 | $78.5K | Buy |
12,463
+6,469
| +108% | +$40.8K | ﹤0.01% | 4910 |
|
|
2023
Q1 | $34.6K | Buy |
+5,994
| New | +$34.6K | ﹤0.01% | 5069 |
|
|
2022
Q4 | – | Sell |
-406
| Closed | -$7K | – | 7165 |
|
|
2022
Q3 | $7K | Sell |
406
-30
| -7% | -$517 | ﹤0.01% | 5475 |
|
|
2022
Q2 | $6K | Sell |
436
-217
| -33% | -$2.99K | ﹤0.01% | 5641 |
|
|
2022
Q1 | $10K | Sell |
653
-9,290
| -93% | -$142K | ﹤0.01% | 5906 |
|
|
2021
Q4 | $213K | Buy |
+9,943
| New | +$213K | ﹤0.01% | 4866 |
|